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reason for anticonvulsant discontinuation was lack of
efﬁcacy. Patients had PDN for 34 months on average
prior to starting topiramate. Mean duration of topira-
mate therapy was 17 months; mean total daily dose was
127mg. A total of 57% used topiramate monotherapy.
According to physician assessment, 46% (95% CI 28, 64)
were “very much improved” or “much improved” for
pain, 36% (95% CI 18, 54) for physical activity, and
39% (95% CI 21, 57) for sleep. None had worsening of
symptoms. A total of 32% experienced topiramate-
related adverse effects (AEs). In 67% no action was taken
for AEs. There were no discontinuations due to AEs or
lack of efﬁcacy. CONCLUSIONS: Topiramate was effec-
tive and well-tolerated for the treatment of PDN, even in
a group of difﬁcult to treat patients for whom other anti-
convulsants had failed.
PAIN—Cost Studies
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The management of back pain is controversial. Despite a
high incidence (between 15% and 40% in most Western
countries) and associated economic burden, considerable
uncertainty exists as to the effectiveness and cost-
effectiveness of alternative interventions for the condi-
tion. OBJECTIVES: To determine whether, from a UK
National Health Service (NHS) perspective, surgical sta-
bilisation of the spine is cost-effective when compared to
an intensive rehabilitation programme for the treatment
of patients with chronic low back pain. STUDY DESIGN:
Three hundred forty-nine patients (349) assessed as
having chronic low back pain were randomised to surgery
(176 patients) or rehabilitation (173 patients) at centres
across the UK. Patients were followed-up at 6, 12, and
24 months post randomisation. METHODS: Costs to the
NHS of initial treatment (surgery or rehabilitation), med-
ications, and all primary and secondary sector health care
contacts were collected for each patient out to 24 months.
Patient utility measured using the EuroQol EQ-5D ques-
tionnaire was combined with 24 month survival data to
calculate quality adjusted life years (QALYs). Results
were expressed using an incremental cost per QALY. Sta-
tistical techniques were used to examine stochastic uncer-
tainty surrounding cost, QALY, and cost per QALY
results. RESULTS: Preliminary analysis shows surgery to
be more costly than rehabilitation at 24 months follow-
ing randomisation. The main cost drivers appear to be
the initial surgical procedure and a higher proportion of
surgery patients receiving subsequent outpatient and
community care. No difference in QALYs was detected
between the two modes of treatment and the baseline
incremental cost per QALY exceeded £30,000. Examina-
tion of uncertainty surrounding key parameters did not
alter these results greatly. CONCLUSION: Preliminary
results from this trial, one of very few in orthopaedic
surgery in the UK, suggest that surgical stabilisation of
the spine for patients with chronic low back pain may be
more costly than alternative treatments with no clear
advantage in successful outcomes.
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OBJECTIVES: Epidemiological studies have consistently
shown that the prevalence of most pain conditions is
higher in women than in men. METHODS: Cross-
sectional survey in the county of Uppland, Sweden, 1995.
The questionnaire was completed by 5404 people
(response rate = 68%); this analysis of those aged 20–64
years included 4506 of the responders. RESULTS: Back
pain (22.7%) and shoulder pain (21.0%) were the most
commonly reported medical problems in the population,
while pain in arms/legs (15.7%) was ﬁfth and headache
(12.5%) was eighth in ranked order of prevalence. Major
gender differences were found. The prevalence of pain
conditions, especially headache, was higher among
women, who also reported more severe pain. Co-
morbidity between pain conditions and psychiatric and
somatic problems was higher among women. Health-
related quality of life (HRQoL; SF-36) also differed with
gender and type of pain. Headache affected the physical
dimensions of the HRQoL scale more in men than in
women, and affected the psychological dimensions more
in women than in men. Although pain conditions were
associated with poorer socioeconomic conditions and life-
style factors in both men and women, there were gender
differences. Education and unemployment were associ-
ated with pain only among men, while economic difﬁ-
culties, part-time work and being married were associated
with pain among women. Obesity, early disability retire-
ment, long term sick-leave and lack of exercise were asso-
ciated with pain conditions in both genders. Factors
associated with pain conditions were unevenly distributed
between genders. CONCLUSION: There are major dif-
ferences between men and women in the prevalence and
severity of self-reported pain in the population. Biologi-
cal factors may explain some of the differences but it is
suggested that the main explanation is the result of gender
disparities in work, economic situation, daily living,
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social life and expectations between women and men.
Deeper societal changes are needed to reduce the
inequities in pain experience between women and men.
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OBJECTIVES: To develop a reliable, valid and sensitive
tool to assess satisfaction with pharmacological pain
treatment among primary care patients. METHODS:
Content sources for the initial version (IV) were biblio-
graphic review, focus groups with patients, and expert
opinion. IV was tested in a prospective study with ambu-
latory pain patients. Item-total statistics and exploratory
factor analysis (FA) were performed for item reduction.
The ﬁnal version (FV) was psychometrically assessed by:
internal consistency (Cronbach’s alpha—CA), test-retest
reliability in patients maintaining treatment (intraclass
correlation coefﬁcient ICC), convergent/discriminant
validity (SF-12 and pain intensity—VAS), construct valid-
ity (lineal multiple regression), extreme groups validity
for patients presenting pain relief (ROC curves) and
responsiveness in patients changing treatment (effect
size—ES). RESULTS: The IV was administered to 362
patients (58% women, age 51y, 48% suffering from
osteoarthritis). Four items were deleted from the IV
owing to a low item-scale homogeneity, leading-weight 
in FA and/or contribution to CA values. The ﬁnal FA
explained 70.2% of the variance. Four dimensions were
identiﬁed: adverse events (AE), speed-duration of effect,
functional beneﬁt and overall satisfaction. A total of
97.2% of patients full-completed the FV. CA for the
global score (GS) was 0.88 and over 0.80 for all dimen-
sions. ICC for GS was 0.73 and ranged from 0.59 (func-
tional beneﬁt) to 0.80 (AE). Correlations were low to
moderate with SF-12 (0.11–0.30) and moderate to good
with VAS (0.48 to 0.55, except AE, 0.20). Pain frequency,
intensity and relief were independently associated with
satisfaction GS, accounting for 43.5% of variance. Area
under the curve was 0.78 for GS and over 0.65 for all
dimensions (except AE, 0.57). ES were large for GS and
dimensions (0.8 to 2.5). CONCLUSIONS: This new 10-
item measure has proved to be reliable, valid and sensi-
tive to assess pharmacological pain treatment satisfaction
in primary care patients.
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OBJECTIVES: To compare patient reported outcomes of
pain and quality of life (QOL) between breast cancer
surgery patients. The analysis compared one patient
group that was on a critical pathway to a patient group
that was not on a critical pathway during their hospital
stay. METHODS: A quasi-experimental study of patients
discharged for breast cancer surgery at a community-
based teaching hospital. The analysis for this study
included 3 distinct patient-reported pain ratings 3–6 days
post-discharge: highest and lowest levels since discharge
and current level of pain at the time of assessment. Addi-
tionally, patients completed the Functional Assessment of
Cancer Therapy-Breast Subscale (FACT-B) six months
post-discharge. Data were collected via telephone inter-
view. RESULTS: Study groups were found to have similar
sociodemographic characteristics. There were no statisti-
cally signiﬁcant differences between the study groups for
the pain or QOL outcomes. Length of stay (LOS) was
found to be statistically signiﬁcant between the pathway
and non-pathway groups (p = 0.020). A total of 77.3%
of the pathway group and 76.7% of the non-pathway
reported pain ratings ≥3 when rating their highest level
of pain since discharge. CONCLUSIONS: Regardless of
pathway status, patients reported similar outcomes of
pain and QOL. The implementation of the pathway
helped formalize the care delivered at the institution.
While the ﬁndings illustrate consistent delivery of care
regardless of pathway status, they also indicate further
attention to pain management post-discharge is needed.
Over 75% of patients in both groups did not meet the
pathway standard when rating their highest level of pain.
The pathway can serve as an informative tool by identi-
fying areas for improvement. The data gathered can be
used as a baseline comparison measure once these areas
have been identiﬁed and changes implemented. Future
research should evaluate pathways and their impact on
patient care after a patient has been discharged from the
hospital.
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OBJECTIVES: To measure the willingness-to-pay of
patients who suffer from benign and intense chronic pain
and to investigate the relationship with the social and
demographic characteristics of the sample and the stated
and perceived quality of life. METHODS: Data from a
research on a sample of 205 and 158 patients suffering
from intense and chronic pain will be discussed, as in the
questionnaire it was asked how much every patient would
